Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets

PHASE1CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 8, 2023

Primary Completion Date

June 16, 2023

Study Completion Date

August 29, 2023

Conditions
Healthy
Interventions
DRUG

Rivaroxaban 10 mg film-coated tablet

One tablet of the test drug was given orally after an overnight fast.

DRUG

Xarelto 10 mg film-coated tablet

One tablet of the reference drug was given orally after an overnight fast.

Trial Locations (1)

12430

PT Equilab International, Jakarta

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

PT Equilab International

INDUSTRY

lead

Dexa Medica Group

INDUSTRY

NCT06558058 - Bioequivalence Study of Rivaroxaban 10 mg Film-coated Tablets | Biotech Hunter | Biotech Hunter